Figure 1From: Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD studyStudy design. ACL400/FOR12 FDC, fixed-dose combination of aclidinium 400ÎĽg and formoterol 12ÎĽg; ACL400/FOR6 FDC, fixed-dose combination of aclidinium 400ÎĽg and formoterol 6ÎĽg; D, day; Wk, week.Back to article page